Oxcarbazepine 600 mg Tablet PCD Franchise in Ahmedabad

Epilepsy Treatment Pharma Supplier in Bangalore

Anti-Seizure Medication Distributor in Hyderabad

Neurology Segment PCD Pharma Franchise in Kolkata

Oxcarbazepine 600 Tablet Stockist in Pune
CNS Medicines Export and Manufacturing in Chandigarh

Home/Products /oxcarbazepine-600mg-tablet

Oxcelzine 600 Tablet

Composition : Oxcarbazepine (600mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹379/-

Oxcelzine 600 Tablet contains Oxcarbazepine 600mg, a well-recognized anti-epileptic medication used to treat and manage partial seizures, generalized tonic-clonic seizures, and epilepsy-related neurological disorders. It works by stabilizing electrical nerve activity in the brain, preventing abnormal impulses that trigger seizures.

This medicine belongs to the neurology and CNS therapeutic segment and is commonly prescribed by neurologists and epilepsy specialists. Oxcarbazepine is known for its long-term therapeutic use and high clinical acceptance, making it a frequent prescription in hospitals, clinics, and specialty care centers.

With strong demand in the chronic epileptic care market, Oxcelzine 600 Tablet offers a stable and high-value opportunity for PCD pharma franchising, institutional supply, and wholesale distribution. It is also available for contract manufacturing, export orders, and private-label branding with competitive trade margins.

For distributors and pharma franchise partners in India, this product represents a fast-growing CNS category segment with reliable repeat demand and strong prescription sustainability.

Read More

About the Product

Oxcelzine 600 Tablet contains Oxcarbazepine 600mg, a well-recognized anti-epileptic medication used to treat and manage partial seizures, generalized tonic-clonic seizures, and epilepsy-related neurological disorders. It works by stabilizing electrical nerve activity in the brain, preventing abnormal impulses that trigger seizures.

This medicine belongs to the neurology and CNS therapeutic segment and is commonly prescribed by neurologists and epilepsy specialists. Oxcarbazepine is known for its long-term therapeutic use and high clinical acceptance, making it a frequent prescription in hospitals, clinics, and specialty care centers.

With strong demand in the chronic epileptic care market, Oxcelzine 600 Tablet offers a stable and high-value opportunity for PCD pharma franchising, institutional supply, and wholesale distribution. It is also available for contract manufacturing, export orders, and private-label branding with competitive trade margins.

For distributors and pharma franchise partners in India, this product represents a fast-growing CNS category segment with reliable repeat demand and strong prescription sustainability.

Dizziness, sleepiness, blurred vision, nausea, fatigue, headache, balance issues, or low sodium levels. Rarely, allergic reactions or skin rash may occur.

Used for the treatment of epilepsy, partial seizures, generalized tonic-clonic seizures, and sometimes mood disorders such as bipolar disorder (as prescribed by a doctor).

Do not stop Oxcelzine 600 suddenly without medical advice. Avoid alcohol and operating machinery until you know its effect. Regular monitoring of sodium levels may be required.

Store below 25°C, in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation